Attempts to find “the right balance” are more likely to throw the sunscreen market wildly out of balance.
Despite its exciting potential, esketamine is receiving significantly more attention for being similar to the street drug ketamine.
Evidence suggests that competition, not politicians, would provide the best chance to help diabetics obtain their life-prolonging medication.
When treatments are unavailable, and prognoses are fatal, the best chance to prolong life is to consider all remaining options.
With U.S. drug prices among the highest in the world, generics provide significant financial relief for millions using prescription drugs.
The FDA’s efforts to reduce teen vaping rates will likely result in worse health outcomes by prompting teens to switch to smoking cigarettes.
Epidemics are causes for concern, but before we declare regulation to be the cure, we should question who administers the treatment.
The FDA’s influence in the prescription drug market remains the largest obstacle to deregulation.
Stringent regulations on the e-cigarette market to come.
Right-to-try will never reach its potential without deregulation.